JAVMA news
Policy changes clarify veterinarians' roles, responsibilities
A series of policy changes are intended to clarify the AVMA's policies on the roles and responsibilities of veterinarians in in pharmaceutical use,…
JAVMA news
Veterinary marijuana?
Most Americans see marijuana as a legitimate medical treatment for some human disease conditions.
JAVMA news
Synthetic opioids put police dogs at risk
Sgt. Scott Kivet thinks about overdose risks to his drug detection dog, Quori, every time they search a vehicle.
JAVMA news
Frustration mounts over opioid shortage
Drug shortages and discontinuations are nothing new to veterinary medicine.
JAVMA news
AVMA presents Excellence in Research Awards
Four veterinarians received the AVMA Excellence in Research Awards during the National Veterinary Scholars Symposium
JAVMA news
More tools needed for disasters, depopulation
Short supplies and limited tools may slow depopulation efforts or leave animals without pain relief during emergencies.
JAVMA news
Groups provide new guidance on antimicrobials
The AVMA, Canadian VMA, and Federation of Veterinarians of Europe are calling for continuous monitoring of antimicrobial use and resistance at a…
Compounding from bulk drug substances
Learn about GFI #256, which clarifies the circumstances under which FDA does not intend to pursue enforcement action for compounding animal drugs from…
AVMA news
Grants, student awards handed out by AVMF, partners
The American Veterinary Medical Foundation and the Veterinary Pharmacology Research Foundation announced the two recipients of pharmacology research…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
AVMA news
AVMF, VPRF announce pharmacology research grant winners
The American Veterinary Medical Foundation (AVMF) and the Veterinary Pharmacology Research Foundation (VPRF) selected two veterinary researchers as…
AVMA news
Monoclonal antibodies show promise as new therapy for veterinary patients
More than 100 monoclonal antibodies (mAb) designed to bind to specific target proteins are available for humans, including those intended to treat…